InvestorsHub Logo
Followers 10
Posts 1672
Boards Moderated 1
Alias Born 11/13/2018

Re: None

Wednesday, 02/02/2022 11:21:35 AM

Wednesday, February 02, 2022 11:21:35 AM

Post# of 70340
So this is the highlights of last quarter. Hopefully we get a nice surprise with that 10m sale to cantek.

Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings
Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021
Adjusted EBITDA Excluding Restructuring Costs Improved by $4.0 million to a loss of $11.5 million versus Q4 2021; Clear Pathway to Adjusted EBITDA Profitability by H1/FY23
Improved Adjusted Gross Margin before FVA of 54% versus 53% in Q4 2021
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACB News